About: Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment of negative symptoms in patients with schizophrenia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.57 (+9.36%)
NERV NASDAQ Minerva Neurosciences Inc
Minerva Neurosciences Inc share price
NERV price activity
Last Price
$2.550
Change (24hr)
-0.02 USD (0.78%)
Volume
9.54K
Volume (4w avg)
-
Open
$2.41
Day Range
$2.41 - $2.63
Previous Close
$2.57
Last Trade
05 Nov, 2:30 pm GMT+0
Delayed
05 Nov, 2:30 pm GMT+0
NERV price performance
Delayed
05 Nov, 2:30 pm GMT+0
NERV details
NERV Market Signals